AbbVie Inc. vs Pfizer Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- AbbVie Inc. is the larger company by market value: $514.0 B against $170.7 B for Pfizer Inc., 3.0 times as much (market caps of Oct 30, 2026).
- Pfizer Inc. had more revenue: $62.6 B against $61.2 B for AbbVie Inc., both in the year to December 2025.
- Pfizer Inc. earned more: net income of $7.8 B against $4.2 B for AbbVie Inc.
- Pfizer Inc. keeps more of each dollar of sales: a net margin of 12.4% against 6.9% for AbbVie Inc.
- Pfizer Inc. employs more people: 75,000 against 57,000 at AbbVie Inc. Each employee brings in about $1,072,982 of revenue at AbbVie Inc. and $834,387 at Pfizer Inc.
- On price to earnings, AbbVie Inc. trades at 49.7× and Pfizer Inc. at 42.3×: investors pay more for each dollar of AbbVie Inc.'s profit.
- AbbVie Inc.'s revenue grew faster in its latest fiscal year: +8.6% against -1.6% for Pfizer Inc.
- On the Piotroski F-score, a nine-point test of improving finances, AbbVie Inc. scores 8 and Pfizer Inc. 5.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | AbbVie Inc. ABBV · #27 in the world | Pfizer Inc. PFE · #127 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | 2013 | 1849 |
| Size | ||
| Market cap | $514.0 B | $170.7 B |
| Revenue | $61.2 B | $62.6 B |
| Net income | $4.2 B | $7.8 B▲ best |
| Employees | 57,000 | 75,000 |
| Valuation | ||
| P/E ratio | 49.7× | 42.3× |
| Price to sales | 7.8× | 2.7× |
| Price to book | — | 2.0× |
| Free cash flow yield | 3.5% | 5.3%▲ best |
| Profitability | ||
| Gross margin | 70.2% | 74.3%▲ best |
| Operating margin | 24.6% | — |
| Net margin | 6.9% | 12.4%▲ best |
| Return on equity | — | 8.9% |
| Return on invested capital | 16.0% | — |
| Growth | ||
| Revenue growth | 8.6%▲ best | -1.6% |
| Revenue growth, 3 years a year | 1.8%▲ best | -14.8% |
| Earnings per share growth | -1.3%▲ best | -3.5% |
| Financial strength | ||
| Debt to equity | — | 0.7× |
| Interest cover | 5.2× | — |
| Cash | ||
| Free cash flow margin | 29.1%▲ best | 14.5% |
| Shareholder returns | ||
| Dividend yield | 2.3% | — |
| Shareholder yield | 2.5% | — |
| Strength scores | ||
| Piotroski F-score | 8 of 9▲ best | 5 of 9 |
| Altman Z-score zone | grey | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, AbbVie Inc. or Pfizer Inc.?
AbbVie Inc. is the larger company by market value: $514.0 B against $170.7 B for Pfizer Inc., 3.0 times as much (market caps of Oct 30, 2026).
Which makes more money, AbbVie Inc. or Pfizer Inc.?
Pfizer Inc. had more revenue: $62.6 B against $61.2 B for AbbVie Inc., both in the year to December 2025. Pfizer Inc. earned more: net income of $7.8 B against $4.2 B for AbbVie Inc.
Which is more profitable, AbbVie Inc. or Pfizer Inc.?
Pfizer Inc. keeps more of each dollar of sales: a net margin of 12.4% against 6.9% for AbbVie Inc.
Which has more employees, AbbVie Inc. or Pfizer Inc.?
Pfizer Inc. employs more people: 75,000 against 57,000 at AbbVie Inc. Each employee brings in about $1,072,982 of revenue at AbbVie Inc. and $834,387 at Pfizer Inc.
Is AbbVie Inc. cheaper than Pfizer Inc.?
On price to earnings, AbbVie Inc. trades at 49.7× and Pfizer Inc. at 42.3×: investors pay more for each dollar of AbbVie Inc.'s profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.
Which is growing faster, AbbVie Inc. or Pfizer Inc.?
AbbVie Inc.'s revenue grew faster in its latest fiscal year: +8.6% against -1.6% for Pfizer Inc.
Which is financially stronger, AbbVie Inc. or Pfizer Inc.?
On the Piotroski F-score, a nine-point test of improving finances, AbbVie Inc. scores 8 and Pfizer Inc. 5.